We’ve formed a partnership with Boston and Los Angeles-based CYTO Consulting to help more North American medtech and life sciences companies grow in China, Japan, South Korea and Taiwan.
CYTO Consulting was founded in 2014 by Dr Odilo Mueller and provides hands-on support to international life sciences companies seeking to commercialize novel technologies in the United States.
Odilo formerly held leadership roles at diagnostic and life science companies Agilent, Merck/EMD Millipore, Danaher/AB SCIEX, and Abcam where he rolled out global innovations - including the launch of the world’s first analytical microfluidics platform. He also draws on his expertise in genomics and proteomics to provide consulting services to companies from global Fortune 500 companies to startups.
Odilo is supported at CYTO by a team of scientific and business executives who have extensive experience in the research, clinical and molecular diagnostics markets and are adept in assessing opportunities for global growth.
The CYTO team will work alongside our own Medtech & Life Sciences Practice teams in Boston, Los Angeles, and Silicon Valley to support North American companies with ambitions to expand in China, Japan, South Korea and Taiwan.
Odilo said: “We’re excited to be working with Intralink, given the company’s 30-year track record in enabling western firms to expand in East Asia. It means we can now support US life sciences companies that would like to grasp the huge growth potential this region has to offer.”
If you’d like to discuss the opportunities for your medical business in East Asia, contact Sol Bergen Bartel on email@example.com.